N@N

Urologix Inc (NASDAQ:ULGX), Down By 8.00% ($0.06) From $0.750 After BUYINS.NET Report Predicted Weakness After Earnings

^{Published on 2013-01-25 13:45:34 - WOPRAI}
 

January 25, 2013 / M2 PRESSWIRE / BUYINS.NET, www.buyins.net , a provider of unique trading technologies, released a report on Wednesday, January 23rd 2013 stating that Urologix Inc (NASDAQ:ULGX) was expected to be Down After its earnings release. Click here to view the BUYINS.NET report: http://www.buyins.net/releases/?sym=ulgx&id=342471

At the time this story was written, Urologix Inc (NASDAQ:ULGX) is Down By 8.00% ($0.06) From $0.750 since the BUYINS.NET report was released.

The movement of stock prices in the days and weeks leading to and following earnings announcements may follow a predictable pattern. Most companies stock price histories show random or unpredictable movements around earnings dates. But some seem to repeat the same pattern quarter after quarter, year after year. The specific technology used to make these predictions is available for a low monthly fee at http://www.squeezetrigger.com/services/strat/mh.php

Urologix Inc (NASDAQ:ULGX) - Urologix, Inc. engages in the development, manufacture, and marketing of non-surgical, office-based therapies for the treatment of the symptoms and obstruction resulting from non-cancerous prostate enlargement, benign prostatic hyperplasia (BPH). The company offers control units, and catheter procedure kits. Its systems uses the Cooled ThermoTherapy technology, a targeted microwave energy combined with a cooling mechanism that protects healthy tissue and enhances patient comfort, as well as provides relief from the symptoms of BPH by the thermal ablation of hyperplasic prostatic tissue. The company markets its control units under the CoolWave and Targis names; and procedure kits under the CTC Advance and Targis names. Urologix, Inc. sells its products to urologists, ambulatory surgery centers, and hospitals through its direct sales force, as well as distributors in the United States and internationally. The company was founded in 1991 and is based in Minneapolis, Minnesota..

About BUYINS.NET

BUYINS.NET, www.buyins.net , monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market-maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:

REGULATORY & COMPLIANCE NEWS

Friction Factor -- market-maker surveillance system tracking market makers in all stocks to determine Price Friction and compliance with new "Fair Market-Making Requirements".

RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and all Threshold Security Lists daily for which stocks have naked short positions.

INVESTMENTS & TRADING

SqueezeTrigger -- 28 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.

Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.

Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.

Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.

Pattern Scan -- automates tracking of every technical pattern and predicts next move in stocks.

GATS -- tracks and quantifies known trading strategies.

DISCLAIMER:

BUYINS.NET is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. Urologix Inc (NASDAQ:ULGX) has not approved the statements made in this release. Please read our report and visit our web site, http://www.buyins.net, for complete risks and disclosures.

Contact: BUYINS.NET Thomas Ronk 800-715-9999 tom@buyins.net http://www.buyins.net